Foresite Capital Management Iv, LLC Portfolio Holdings

Foresite Capital Management Iv, LLC

  • $153 Million
  • Q3 2024

Foresite Capital Management Iv, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $153 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $81.4M, Kura Oncology, Inc. with a value of $36.1M, Syndax Pharmaceuticals Inc with a value of $16.8M, Lyell Immunopharma, Inc. with a value of $11.5M, and Relay Therapeutics, Inc. with a value of $7.08M.

Examining the 13F form we can see an increase of $4.16M in the current position value, from $149M to 153M.

Foresite Capital Management Iv, LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Management Iv, LLC portfolio as well as his latest detailed transactions.

Portfolio value $153 Million
Healthcare: $153 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $153 Million
  • Prior Value $149 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email